Home / India / India to Launch First Domestically Developed H5N1 Bird Flu Vaccine for Poultry on November 20

India to Launch First Domestically Developed H5N1 Bird Flu Vaccine for Poultry on November 20

NEW DELHI, Nov. 18, 2026 — Union Agriculture and Farmers Welfare Minister Shivraj Singh Chouhan will formally dedicate India’s first domestically produced vaccine against the H5N1 (Clade 2.3.2.1a) avian influenza virus in chickens on November 20, 2026, at a ceremony in Bhopal.

Created by researchers at the Bhopal-based ICAR-National Institute of High Security Animal Diseases (ICAR-NIHSAD), the inactivated formulation represents the country’s first targeted immunization specifically engineered to combat the Clade 2.3.2.1a strain of Highly Pathogenic Avian Influenza (HPAI). Until now, no commercial vaccine tailored to this specific viral clade has been available on the market.

Economic and Agricultural Impact Bird flu outbreaks frequently trigger mortality rates approaching 100 percent in infected flocks, forcing mass culling operations and trade suspensions that severely disrupt poultry pricing and farmer incomes. Since avian influenza was first identified in India in 2006, authorities have documented over 500 combined outbreaks involving the H5N1 and H5N8 subtypes.

Historical data underscores the severe financial toll of uncontrolled transmission:

  • National GDP Risk: An unchecked, large-scale epidemic threatens over 20 percent of India’s poultry stock and could shave up to 1.5 percent off national GDP growth.
  • Past Economic Losses: The initial 2006 epidemic generated between Rs. 2,200 crore and Rs. 3,000 crore in combined direct and indirect damages, while a separate outbreak in Manipur cost the state 0.5 percent of its GDP.

Public Health and Cross-Species Concerns Virological surveillance indicates that the Clade 2.3.2.1a variant drives the majority of avian influenza infections among domestic chickens in India. Recently, however, scientists have also detected spillover infections from this clade in mammals, alongside three confirmed human infections.

Globally, avian influenza remains a persistent zoonotic threat. Figures compiled by the World Health Organization (WHO) show that since 2003, 1,003 human H5N1 infections—resulting in 479 fatalities—have been recorded across 25 nations, including India. By deploying ICAR-NIHSAD’s new vaccine to immunize poultry against circulating Clade 2.3.2.1a strains, officials aim to safeguard rural livelihoods while curbing cross-species viral transmission to mammals and humans.

PIB

Leave a Reply

Your email address will not be published. Required fields are marked *